Conexo GovU.S. federal contracts
English

INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.: federal contracts won

Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: Z82HHPY83MC7

4contracts won
$947,650total obligated
$255,785median contract
Sep 25, 2026most recent start

Agencies it works for

AgencyContractsObligated
Department of Health and Human Services4$947,650

Industries (NAICS)

NAICSContractsObligated
541714 Research and Development in Biotechnology (except Nanobiotechnology)3$622,650
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)1$325,000

Where it works

New York 4

Recent contracts

ContractWinnerAgencyObligatedStart
C02 - PK-PD ANALYSIS OF MOUSE MODEL EFFICACY AND PK DATA FOR ANTIBACTERIAL COMPOUNDS
75N93026F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Schenectady, NY
— Department of Health and Human Services
National Institutes of Health
$111,080
Potential value: $333,240
Sep 25, 2026
Ends: Jul 14, 2031
BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
75F40126C00025 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Schenectady, NY
— Department of Health and Human Services
Food and Drug Administration
$325,000 Aug 01, 2026
Ends: Jul 31, 2027
FDABAA-24-00123: DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR NITROFURANTOIN DOSING USING A DYNAMIC URINARY TRACT IN VITRO INFECTIO…
75F40124C00080 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Schenectady, NY
— Department of Health and Human Services
Food and Drug Administration
$248,553 Aug 19, 2024
Ends: Oct 29, 2025
THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPE…
75F40123C00140 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Schenectady, NY
— Department of Health and Human Services
Food and Drug Administration
$263,016 Sep 18, 2023
Ends: Jun 24, 2025

Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.